21488 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Macromolecular compounds Linear polymers, e.g. dextran, inulin, PEG
Sub-classes:CUSTOMIZABLE LYOPHILIZED AGENT FOR IMAGE-GUIDED RADIOTHERAPY AND DRUG DELIVERY
#2SINGLE-POLYMER PARTICLES, ACTIVE MOLECULAR COMPLEX, METHOD FOR PRODUCING SINGLE-POLYMER PARTICLES, METHOD FOR MEASURING TUMOR SIZE, METHOD FOR MEASURING FINE STRUCTURE WITHIN TUMOR, METHOD FOR IMAGING BIOLOGICAL TISSUE, DRUG DELIVERY SYSTEM, AND CONTRAST AGENT KIT
#3MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#4METHODS FOR MAGNETIC RESONANCE IMAGING OF NANOCONSTRUCTS AND USES THEREOF
#5DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES
#6SYNTHETIC CYCLIC PEPTIDE MIMETICS
#7Injection Molded Medical Devices Made From A High Molecular Weight Polyethylene
#8CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#9MULTIFUNCTIONAL CONTRAST AGENTS, COMPOSITIONS, AND METHODS
#10TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF
#11Biocompatible magnetic materials
#12Radiopaque monomers, polymers, microspheres, and methods related thereto
#13TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#14MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#15TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER
#16Methods and compositions for deuterated biologics
#17Targeted protein contrast agents, methods of making, and uses thereof
#18Contrast agents, methods for preparing contrast agents, and methods of imaging
#19Targeted protein contrast agents, methods of making, and uses thereof
#20Injection molded medical devices made from a high molecular weight polyethylene
#21Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility
#22MRI imaging of amyloid plaque using liposomes
#23MRI IMAGING OF AMYLOID PLAQUE USING LIPOSOMES
#24Conjugated polymer-based nanoprobe and preparation method and application thereof
#25Imaging compositions
#26BIOCOMPATIBLE MAGNETIC MATERIALS
#27Radiopaque monomers, polymers, microspheres, and methods related thereto
#28COMPLEXES BETWEEN BLOCK POLYMERS AND IONS AS CONTRAST AGENTS FOR MEDICAL IMAGING
#29Targeted protein contrast agents, methods of making, and uses thereof
#30Contrast agents, methods for preparing contrast agents, and methods of imaging
#31FERROMAGNETIC PARTICLES BOUND TO POLYMERIC IMPLANTS
#32SIDE-CHAIN CRYSTALLIZABLE POLYMERS FOR MEDICAL APPLICATIONS
#33RARE EARTH-BASED NANOPARTICLE MAGNETIC RESONANCE CONTRAST AGENT AND PREPARATION METHOD THEREOF
#34Glucose conjugated gold nanoparticle
#35PROCESS FOR PRODUCING NANOPARTICLES
#36MAGNETIC AND FLUORESCENT REVERSE NANOASSEMBLIES
#37MRI imaging of amyloid plaque using liposomes
#38Compositions and Methods to Image and Quantify Inflammation
#39Suicide contrast agents targeting HIV reservoirs for theranostic eradication
#40Biodegradable organic radical-functionalized polycarbonates for medical applications
#41Radiopaque monomers, polymers, microspheres, and methods related thereto
#42MRI imaging of amyloid plaque using liposomes
#43MRI contrasting agent for contrasting cancer cell
#44Self-assembled pharmaceutical composition for photodynamic therapy
#45COMPOSITION-CONTROLLED NOBLE METAL-TRANSITION METAL SMALL NANOPARTICLE ALLOYS WITH NIR-EMISSION AND HIGH T2 RELAXIVITY AND METHOD FOR MAKING SAME
#46COMPOSITIONS OF SACCHARIDE COATED NANOPARTICLES AND USES
#47MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#48MR IMAGING DIAGNOSTIC AGENT FOR INTRACTABLE NEUROLOGICAL DISEASE
#49NANOPARTICLES FOR BRAIN TUMOR IMAGING
#50Magnetic and fluorescent reverse nanoassemblies
#51Magnetic nanoparticles
#52Gold/lanthanide nanoparticle conjugates and uses thereof
#53Chelating amphiphilic polymers
#54Compounds and their effects on appetite control and insulin sensitivity
#55Embolic devices
#56Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
#57Polymeric nanocarriers with linear dual response mechanism
#58Polymer, contrast agent for nuclear magnetic resonance analysis or magnetic resonance imaging using the polymer, compound and method of nuclear magnetic resonance analysis and method of magnetic resonance imaging using the polymer
#59MMP-TARGETED THERAPEUTIC AND/OR DIAGNOSTIC NANOCARRIERS
#60Chemically-linked nanoparticles
#61Probes, Methods of Making Probes, and Methods of Use
#62Iron oxide nanocapsule, method of manufacturing the same, and MRI contrast agent using the same
#63MRI-visible hydrophobic copolymer
#64Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
#65NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS
#66Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
#67Theranostic imaging agents and methods of use
#68High-sensitivity magnetic resonance imaging nano-contrast agent based on an anionic polymer and cationic polymer ion complex, and a production method therefor
#69Contrast enhancement agents and method of use thereof
#70CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME
#71MRI contrast agents
#72Embolic devices
#73AMPHIPHILIC POLYMERS AND METHODS OF USE THEREOF
#74PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded
#75Compositions and methods comprising magnetic resonance contrast agents
#76CHEMICAL COMPOSITIONS TO DETECT AND TREAT AMYLOID IN A PATIENTS BRAIN AND RETINA
#77METHOD FOR THE PRODUCTION OF SCAFFOLDS FOR TISSUE ENGINEERING, COMPRISING THE USEOF AN ANCHORING UNIT, AND SCAFFOLD PRODUCED THEREWITH
#78Compositions, methods, and systems comprising fluorous-soluble polymers
#79Use of a fluorinated polymer as a contrast agent in solid state 19F magnetic resonance imaging (MRI), scaffold comprising said polymer and use thereof
#80MRI T1 CONTRASTING AGENT COMPRISING MANGANESE OXIDE NANOPARTICLE
#81Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
#82Polymeric nano-carriers with a linear dual response mechanism and uses thereof
#83Gold/lanthanide nanoparticle conjugates and uses thereof
#84METHODS FOR MAGNETIC RESONANCE IMAGING
#85SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A METAL-CHELATING LIGAND
#86Method of Preparation of DTPA Crosslinked Hyaluronic Acid Derivatives and Modification of Said Dervivatives
#87Side-chain crystallizable polymers for medical applications
#88Molecular imaging
#89Chelating amphiphilic polymers
#90Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
#91Polymerized cyclic nitroxide radical compound and use thereof
#92MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS
#93REMOTE DETECTION OF SUBSTANCE DELIVERY TO CELLS
#94CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#95ULTRA-SMALL CHITOSAN NANOPARTICLES USEFUL AS BIOIMAGING AGENTS AND METHODS OF MAKING SAME
#96Organic-inorganic hybrid particles containing contrast agent
#97Nanoparticles for brain tumor imaging
#98IMAGING NUCLEIC ACID BINDING PROTEINS
#99Simple method for introducing magnetic particles into a polymer
#100Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
#101METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS
#102Multi-component biological transport systems
#103Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
#104Imaging Cellular Nucleic Acids
#105Methods and Compositions for Imaging and Biomedical Applications
#106Dual function polymer micelles
#107Diagnostic agents for pancreatic exocrine function
#108Block copolymers and nano micelles comprising the same
#109Block copolymers and nano micelles comprising the same
#110Amphiphilic polymers and methods of use thereof
#111Side-chain crystallizable polymers for medical applications
#112Dose dependent elimination of HA and cell receptor stimulation
#113Methods for magnetic resonance imaging
#114Biochemically-activated contrast agents for magnetic resonance imaging
#115Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
#116Remote detection of substance delivery to cells
#117Diagnostic agents for pancreatic exocrine function
#118Diagnostic agents for pancreatic exocrine function
#119Diagnostic agents for pancreatic exocrine function
#120Hydroxypyridonate and hydroxypyrimidinone chelating agents
#121Micro/nano magnetic hydrogels with autofluorescence for therapeutic and diagnostic applications